Fixed drug eruptions to human immunodeficiency virus-1 protease inhibitor.
Despite numerous drug interactions that occur with human immunodeficiency virus-1 protease inhibitors, there are relatively few drug reactions. We present two patients receiving saquinavir who developed fixed drug reactions. Both reactions cleared while patients received a therapeutic dose of the medication, and in one patient a flare was seen when the patient later stopped and then restarted the medication. Although fixed drug reactions are relatively inconsequential, it is important to know that these eruptions may clear when the patient is given uninterrupted therapy of a human immunodeficiency virus-1 protease inhibitor, with only post-inflammatory hyperpigmentation.
Smith
K J
KJ
Department of Dermatology, National Naval Medical Center, Bethesda, Maryland, USA.
Yeager
J
J
Skelton
H
H
D000328:Adult; D001706:Biopsy; D003937:Diagnosis, Differential; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology* / Q000473:pathology; D015658:HIV Infections / Q000188:drug therapy* / Q000473:pathology; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D015497:HIV-1 / Q000187:drug effects*; D006801:Humans; D008297:Male; D019258:Saquinavir / Q000008:administration & dosage / Q000009:adverse effects*; D012867:Skin / Q000473:pathology
D017320:HIV Protease Inhibitors; D019258:Saquinavir